Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Oral Oncol. 2021 Apr 4;117:105270. doi: 10.1016/j.oraloncology.2021.105270

Table 1:

Patient Demographics

Age at Diagnosis Gender Site Overall Stage TNM stage Special IHC stains Smoking
Status
Adjuvant
Treatment
Recurrence Disease
Status
Time from
treatment
55 F Hard palate IV T4aN0M0 none Former no no AWOD 8 years
41 F Hard palate I T1N0M0 none Never no no NED at last follow up 4 years
56 M Mandible unknown
initial stage
N1 recurrence none Current Second surgery for nodal
recurrence
Regional NED at last follow up 17 yrs from initial disease
5 yrs since
nodal
recurrence
41 F BOT IV T4aN2bM0 none Current CRT no AWOD 1.8 years
58 F Nasopharynx III T3N0M0 none Never salvage surgery after CRT no AWOD 1.6 years
54 M BOT II T2N0M0 Positive for cytokeratin, EMA and vimentin (focally). PAS stain positive and mucicarmine negative Never no Local AWOD 17 years from initial disease 8 months local
recurrence
57 F BOT, FOM, and oral tongue IV T3N2bM0 none Never RT no AWOD 1 month
48 M Nasopharynx I T1N0M0 Positive for p63 and focally/weakly for CAM5.2. Negative for calponin, C-kit, smooth muscle
actin and S100. Mucicarmine stain is negative for intracytoplasmic
mucin
Never no no NED at last follow up 2.7 years